Loading...

IL-2, the next best thing in chronic GVHD therapy?

In this issue of Blood, Koreth et al have reported that interleukin-2 (IL-2) is effective in chronic graft-versus-host disease (cGVHD) patients who had failed up to two prior lines of therapy.(1)

Na minha lista:
Bibliografiske detaljer
Udgivet i:Blood
Main Authors: Curtis, Lauren M., Pavletic, Steven Z.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4937357/
https://ncbi.nlm.nih.gov/pubmed/27389542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-05-711796
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!